publication date: Dec. 19, 2010

In this issue: 

Stop suffering and death “all around us”? Von Eschenbach speeches at FDA omit 2015 goal.

FDA, NCI, CMS announce biomarker initiative; first project to validate FDG-PET as predictor of tumor response in non-Hodgkin’s lymphoma.

NCI forms new committees to oversee cancer clinical trials.

Download (PDF )

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.